Cat Huss
Family · Winter Park, FLNPI 1710485511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2022 at $2,743 and has fallen 99.1% since, to $24 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $36.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$598
- Novo Nordisk$517
- AstraZeneca$358
- Otsuka America Pharmaceutical, Inc.$286
- Lilly USA, LLC$279
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $1,193 |
| Teva Pharmaceuticals USA, Inc. | 5 | $598 |
| Novo Nordisk | 14 | $517 |
| AstraZeneca | 10 | $358 |
| Otsuka America Pharmaceutical, Inc. | 6 | $286 |
| Lilly USA, LLC | 11 | $279 |
| Amgen | 6 | $213 |
| GSK | 6 | $181 |
| Idorsia Pharmaceuticals US Inc | 2 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Merck | 2 | $113 |
| Amarin Pharma, Inc. | 6 | $111 |
| Boehringer Ingelheim | 5 | $90 |
| Abbott | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Avanir Pharmaceuticals, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Vertex | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,729 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Winter Park
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.